BC Cancer–Kelowna IND240 Clinical Trials Team recognized with IND Team Award

Congratulations to the BC Cancer – Kelowna IND240 Clinical Trials Team on receiving the IND Team Award from the Canadian Cancer Trials Group (CCTG), presented at the CCTG Spring Meeting.

The award recognizes non-MD trial team members for their outstanding contributions and dedication to the success of clinical trials within the IND Program.

New blood test breakthrough advances early detection and prevention in hereditary cancer

A groundbreaking new blood test developed by BC Cancer is changing how families identify and manage inherited cancer risk, eliminating unnecessary testing on one side of a family while bringing life-saving clarity to the other.

BC Cancer scientists have developed a world-first technology, Parent-of-Origin-Aware Genomic Analysis (POAga) which can determine, with 98% accuracy, whether a cancer-causing gene mutation was inherited from a patient's mother or father – using only a single blood sample.

New national survey study aims to improve equity in Canadian cancer clinical trials

A new Canadian Cancer Trials Group (CCTG) survey study, SC32S, has opened across Canada to collect sociodemographic data from cancer clinical trial participants and assess whether asking questions about this information feels appropriate to patients. The patient survey will ask CCTG trial participants about different parts of everyday life that can affect patient health and experience with cancer care.

BC Cancer 2026 Summer Research Studentship Awards announced

Summer research studentships, sponsored by the BC Cancer Foundation, support senior undergraduate university students and/or junior medical or dental students seeking hands-on training in cancer research in British Columbia. These studentships may address any discipline of cancer research including clinical, translational, basic, behavioral and population health. 

Congratulations to this year’s recipients and their supervisors!

Back to top